NM_003978.5:c.36+68G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003978.5(PSTPIP1):​c.36+68G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,609,522 control chromosomes in the GnomAD database, including 50,599 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7798 hom., cov: 33)
Exomes 𝑓: 0.23 ( 42801 hom. )

Consequence

PSTPIP1
NM_003978.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.77

Publications

8 publications found
Variant links:
Genes affected
PSTPIP1 (HGNC:9580): (proline-serine-threonine phosphatase interacting protein 1) This gene encodes a cytoskeletal protein that is highly expressed in hemopoietic tissues. This protein functions via its interaction with several different proteins involved in cytoskeletal organization and inflammatory processes. It binds to the cytoplasmic tail of CD2, an effector of T cell activation and adhesion, downregulating CD2-triggered adhesion. It binds PEST-type protein tyrosine phosphatases (PTP) and directs them to c-Abl kinase to mediate c-Abl dephosphorylation, thereby, regulating c-Abl activity. It also interacts with pyrin, which is found in association with the cytoskeleton in myeloid/monocytic cells and modulates immunoregulatory functions. Mutations in this gene are associated with PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. It is hypothesized that the disease-causing mutations compromise physiologic signaling necessary for the maintenance of a proper inflammatory response. [provided by RefSeq, Mar 2016]
PSTPIP1 Gene-Disease associations (from GenCC):
  • pyogenic arthritis-pyoderma gangrenosum-acne syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • autoinflammatory syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-76995677-G-A is Benign according to our data. Variant chr15-76995677-G-A is described in ClinVar as Benign. ClinVar VariationId is 1182295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.503 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSTPIP1NM_003978.5 linkc.36+68G>A intron_variant Intron 1 of 14 ENST00000558012.6 NP_003969.2 O43586-1A0A0S2Z5P3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSTPIP1ENST00000558012.6 linkc.36+68G>A intron_variant Intron 1 of 14 1 NM_003978.5 ENSP00000452746.1 O43586-1

Frequencies

GnomAD3 genomes
AF:
0.297
AC:
45100
AN:
152072
Hom.:
7777
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.436
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.371
Gnomad ASJ
AF:
0.168
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.325
Gnomad FIN
AF:
0.221
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.199
Gnomad OTH
AF:
0.269
GnomAD4 exome
AF:
0.229
AC:
333063
AN:
1457332
Hom.:
42801
AF XY:
0.227
AC XY:
164704
AN XY:
725124
show subpopulations
African (AFR)
AF:
0.442
AC:
14752
AN:
33338
American (AMR)
AF:
0.452
AC:
20181
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
4156
AN:
26108
East Asian (EAS)
AF:
0.488
AC:
19372
AN:
39672
South Asian (SAS)
AF:
0.290
AC:
24945
AN:
86108
European-Finnish (FIN)
AF:
0.214
AC:
11412
AN:
53284
Middle Eastern (MID)
AF:
0.154
AC:
660
AN:
4298
European-Non Finnish (NFE)
AF:
0.201
AC:
223257
AN:
1109806
Other (OTH)
AF:
0.238
AC:
14328
AN:
60102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
13440
26880
40319
53759
67199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8254
16508
24762
33016
41270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.297
AC:
45149
AN:
152190
Hom.:
7798
Cov.:
33
AF XY:
0.302
AC XY:
22474
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.435
AC:
18074
AN:
41506
American (AMR)
AF:
0.372
AC:
5689
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.168
AC:
584
AN:
3472
East Asian (EAS)
AF:
0.519
AC:
2684
AN:
5170
South Asian (SAS)
AF:
0.323
AC:
1561
AN:
4828
European-Finnish (FIN)
AF:
0.221
AC:
2337
AN:
10598
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.199
AC:
13510
AN:
68002
Other (OTH)
AF:
0.267
AC:
563
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1577
3154
4730
6307
7884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
981
Bravo
AF:
0.313
Asia WGS
AF:
0.411
AC:
1426
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 61% of patients studied by a panel of primary immunodeficiencies. Number of patients: 59. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.22
DANN
Benign
0.42
PhyloP100
-1.8
PromoterAI
0.053
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2254441; hg19: chr15-77288018; API